e-SPACE Heart Failure 2023
Published: 25 October 2023
-
Views:
4279
-
Likes:
7
-
Views:
4279
-
Likes:
7
-
Up Next -
44m 24s
-
1h 1m 52sPart 2 | Session 7 Plenary session 9 – New technologies for HF management
-
1h 2m 8sPart 2 | Session 8 Plenary session 10 – Special Populations
-
1h 54sPart 1 | Session 1 Plenary session 1 – Recent guideline updates in HF Ahmed Bennis, Frieder Braunschweig, Marco Metra, Alicia Chan, Ovidiu Chioncel, Stefan Anker
-
41m 37sPart 1 | Session 2 Meet the expert – Iron Deficiency & IV Iron – The 2023 ESC HF Guidelines and Recent Trial Results: Interpretation & Implementation (Supported by an unrestricted educational grant from Pharmacosmos) Patricia Campbell, Paul Kalra, Robert Mentz
-
1h 8m 32sPart 1 | Session 3 Plenary session 2 – GDMT in the clinical setting Michael Böhm, Frieder Braunschweig, John JV McMurray, Gianluigi Savarese, Marianna Adamo
-
51m 41sPart 1 | Session 4 Special Live Interactive Session – Management of ATTR-CM Brett Sperry, Arnt Kristen, Fabian Knebel, Ahmad Masri
-
44m 4sPart 1 | Session 5 Meet the expert – Best practices in the management of patients with cardiac amyloidosis (Supported by an educational grant from AstraZeneca) Peter van der Meer, Daniela Tomasoni, Marianna Fontana
-
57m 43sPart 1 | Session 6 Plenary session 3 – SGLT2i in clinical practice Stefan Anker, Clara Saldarriaga, Milton Packer, Shelley Zieroth, Muthiah Vaduganathan, Deepak L Bhatt
-
40m 4sPart 1 | Session 7 Meet the expert – Management of patients with HFpEF: What did we learn from our HFrEF patients (Supported by an educational grant from AstraZeneca) Giuseppe Rosano, Clara Saldarriaga, Gianluigi Savarese
-
1h 1m 49sPart 1 | Session 8 Plenary session 4 – Obesity and weight management in HF Mikhail Kosiborod, Massimo Piepoli, Giulia Ferrannini, Wolfram Doehner, Mark Petrie
-
50m 39sPart 1 | Session 9 Special Live Interactive Session – Best practices for hyperkalemia management across the cardiorenal spectrum Giuseppe Rosano, Gianluigi Savarese, Ileana L Piña
-
56m 50sPart 1 | Session 10 Plenary session 5 – Worsening and acute heart failure Gerasimos Filippatos, Ileana L Piña, Marianna Adamo, Piotr Ponikowski, Javed Butler, John R Teerlink
-
36m 3sPart 2 | Session 1 Meet the expert – Iron deficiency and heart failure – what we have learnt so far? (Supported by an unrestricted educational grant from CSL Vifor) Ovidiu Chioncel, Piotr Ponikowski, Andrew Sindone
-
1h 1m 56sPart 2 | Session 2 Plenary session 6 – Iron deficiency: the totality of evidence Piotr Ponikowski, Yuhui Zhang, Ewa Jankowska, John GF Cleland, Stephan Von Haehling
-
25m 15sPart 2 | Session 3 Meet the expert – Practical approaches in the management of hyperkalemia (Supported by an educational grant from AstraZeneca) Shelley Zieroth, Aaron Wong
-
59m 4sPart 2 | Session 4 Plenary session 7 – Managing comorbidities in HF Harriette Van Spall, Brenda Moura, Gerasimos Filippatos, Michael Böhm, João Pedro Ferreira
Overview
Translational Medicine Academy (TMA) in partnership with Radcliffe Cardiology were delighted to announce the return of e-SPACE Heart Failure 2023.
A thoughtfully curated programme supported the exploration of how leading experts are implementing the new heart failure guidelines into clinical practice and showed the latest information on patient profiling in heart failure for tailoring medical therapy.
This event once again brought together TMA’s mandate for the delivery of continuing professional development to healthcare professionals to achieve concordance with appropriate treatment plans, with Radcliffe Cardiology’s goal to deliver cardiovascular knowledge to best support cardiovascular communities transform theory into practice.
Learning Objectives
- Review the burden of heart failure with reduced ejection fraction (HFrEF) and heart failure with preserved ejection fraction (HFpEF) as one of the leading causes of disability and mortality worldwide
- Understand the latest guideline recommendations and discuss their applicability according to patients phenotypes
- Discuss the implementation in clinical practice of the four foundational therapies and additional drugs and devices to improve patient outcomes
- Develop a comprehensive understanding of best practices for the screening, diagnosis and management of the patient with heart failure and comorbidities
- Translate the findings of recent studies and guidelines into optimal patient management
Target Audience
- Heart Failure Specialists
- General Cardiologists
- General Practitioners (GPs)
- Nurses, Pharmacists, and other Allied Healthcare Professionals
More from this programme
Part 1
Day One
Part 2
Day Two
Faculty Biographies
Stefan Anker
Professor of Cardiology
Prof Stefan Anker is professor of (Tissue) Homeostasis in Cardiology & Metabolism at Charité Berlin, Germany, since June 2017. Prodigious researcher who has authored more than 1,000 articles. He has also won several prizes, including the 2018 Copernicus Prize of German DFG & Polish FNP. In October 2020, he was awarded a Doctor honoris causa of Medical University Wroclaw, Poland.
Prof Anker has been serving on the board of the Heart Failure Association (HFA) of the ESC since 2006 and was HFA President from 2012 to 2014. He currently chairs the HFA committee on regulatory affairs. He is founding Editor-in-Chief of the first open-access heart failure journal, ESC Heart Failure. Prof. Anker has served on several ESC Guideline task forces.
Prof Anker is the founding president of the International Society on Sarcopenia, Cachexia and Wasting Disorders (SCWD) and founding Editor-in-Chief of the Journal of Cachexia, Sarcopenia and…
Giuseppe Rosano
Consultant Cardiologist and Professor of Cardiology (Hon)
Giuseppe Rosano is Consultant Cardiologist and Professor of Cardiology at St George’s, University of London, UK where he is also the director of MSc Heart Failure.
Prof Rosano's areas of expertise include heart failure, cardiac metabolism, cardiovascular pharmacology and pharmacotherapy, heart disease in women and cardiovascular effects of sex hormones. He has a specific interest in chronic coronary syndromes and in angina with normal coronary arteries.
Prof Rosano has been core member of the Cardiovascular Working Party of the European Medicines Agency and member of the Pricing and Reimbursement Committee of the Italian…
Javier de Juan Bagudá
Clinical Cardiologist
Dr Javier de Juan Bagudá is a Clinical Cardiologist at University Hospital 12 de Octubre, Madrid, ES.
He is a specialist in heart failure, hypertension and ischemic heart disease.
He has participated as Principal Investigator in several multicenter clinical trials and clinical registries.
Marat Fudim
Assistant Professor
Dr Marat Fudim is a cardiologist, advanced heart failure specialist and assistant professor at Duke University, Durham, US. He has a clinical and research interest in heart failure, including advanced therapies such as mechanical assist devices or "heart pumps" and heart transplantation.
As part of his work, Dr Fudim also performs cardiac catheterizations to understand a patient’s disease.
William T Abraham
Professor of Internal Medicine and Chief of the Division of Cardiovascular Medicine
Prof Abraham is a College of Medicine Distinguished Professor. He has been recognized as one of the “Best Doctors in America” for 18 consecutive years.
His research has led to the approval/adoption of new heart failure therapies, including beta-blockers, natriuretic peptides, cardiac resynchronization therapy, ultrafiltration, implantable hemodynamic monitoring, transvenous phrenic nerve stimulation, cardiac contractility modulation, baroreflex activation therapy, and mitral valve repair.
Prof Abraham has authored more than 1,000 original works and has been named a Clarivate Analytics Highly Cited Researcher and one of The World’s Most Influential Scientific Minds.
He received the 2017 Distinguished Scientist Award from the American College of Cardiology.
With his permission, Prof Abraham is contactable here.
Comments